 |
|
|
| |
Atazanavir plus Cobicistat versus Atazanavir plus Ritonavir, Both in Combination with Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Subgroup Analysis of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial
|
| |
| |
Reported by Jules Levin
EACS 2015 Oct 21-24 Barcelona, Spain
Graeme Moyle,1 Juan Berenguer,2 Edwin DeJesus,3 Joel Gallant,4 Peter Shalit,5 Joel Myers,6 Huyen Cao,7 Lisa Rosenblatt,6 Lingfeng Yang,8 Javier Szwarcberg7
1Chelsea and Westminster Hospital, London, UK; 2Hospital General Universitario Gregorio Marañón, Madrid, Spain; 3Orlando Immunology Center, Orlando, FL, USA; 4Southwest CARE Center, Santa Fe, NM, USA; 5Tribal Med, Seattle, WA, USA; 6Bristol Myers Squibb, Plainsboro, NJ, USA; 7Gilead Sciences, Inc., Foster City, CA, USA; 8Bristol Myers Squibb, Hopewell, NJ, USA
|
| |
|
|
|
|
|
